Indazoles used to treat estrogen receptor beta mediated disorders

Details for Australian Patent Application No. 2008223850 (hide)

Owner Glaxo Group Limited

Inventors Takle, Andrew Kenneth; Jones, David G.; Naylor, Antoinette; Johnson, Christopher Norbert; Macpherson, David Timothy; Trani, Giancarlo; Miller, Aaron B.; Stanway, Steven James; Liang, Xi

Agent Davies Collison Cave

Pub. Number AU-A-2008223850

PCT Pub. Number WO2008/107455

Priority 0704407.6 07.03.07 GB

Filing date 5 March 2008

Wipo publication date 12 September 2008

International Classifications

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

24 September 2009 PCT application entered the National Phase

  PCT publication WO2008/107455 Priority application(s): WO2008/107455

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008223851-Surveillance system and method

2008223848-Skin cleansing agent with particles containing hydrogenated castor oil